miika
Joined 5 years ago
Joined 5 years ago
Then again, I know fruitarian who runs ultramarathons. He eats only sugar, so clearly human body can run on two different fuels very well.
Maybe we shouldn’t mix them but choose just the other? Carbs or fat. It would make sense that if there are two paths to get energy from eating, the system may not run optimally if you keep feeding both at the same time?
How I hack this: I say to myself “I’m never going to do it” and there is an instant feeling if that statement is true or not. Then I either start it right away or let it go.
https://news.harvard.edu/gazette/story/2010/03/alzheimers-as...
Then web site developers could ask these preferences with API and act accordingly. Developers who wouldn’t respect these settings would get bad karma somehow.
Maybe then we could get rid of those annoying boxes that disrupt the browsing flow?
I turned my iPhone into pure utility device by uninstalling all the entertainment apps. I only allow music and podcasts as those don’t require my active attention.
Then I have an iPad mini at home which has all the entertainment and social media stuff installed. However I don’t have many opportunities to use that device during the day..
After maybe a week of having this arrangement I found myself being less and less interested in grabbing that iPad. It’s been few months now and I only check my socials maybe twice a week.
Also since I deleted Facebook, Instagram, Threads, YouTube and TikTok from my phone the battery life almost doubled. It was eye opening to see how much these apps drain battery even when the device is left untouched.
To continue working without coding, while still making use of coding skills and experience, I suppose roles like CTO or technical project lead might be suitable?
https://www.sciencealert.com/alzheimers-may-not-actually-be-...
Alzheimer's may not be primarily a brain disease but rather an autoimmune disorder where the brain's immune system mistakenly attacks its own cells, with beta-amyloid playing a central role.
There is a growing consensus that focusing solely on beta-amyloid has led to stagnation in treatment development, prompting researchers to explore alternative theories and treatment pathways.
Also there is potential fabrication of data in a key 2006 study linking beta-amyloid to Alzheimer's and the FDA's approval of aducanumab, which has faced criticism for its incomplete data.